Hematologic Malignancies
News
Prognostic tool may allow tailored therapy for Hodgkin lymphoma
A newly developed “robust and inexpensive” prognostic tool may allow more tailored therapy for youth with intermediate-risk Hodgkin lymphoma.
News
VA Establishes Presumption of Service Connection for Camp Lejeune
Veterans who served ≥ 30 days at Camp Lejeune and developed 1 of 8 cancer types are eligible for VA reimbursement.
Patient Care
Pretreatment Imaging May Help Prevent Hodgkin Lymphoma Recurrence
Study data reveal pretreatment scanning significantly reduces the risk of relapse and radiation exposure adverse effects in patients with Hodgkin...
News
New approach for monitoring minimum residual disease in multiple myeloma
Next-generation sequencing might be useful to monitor for minimum residual disease in multiple myeloma.
Article
The Link Between Low-Density Lipoproteins and Chronic Lymphocytic Leukemia
Researchers explored the connection of low-density lipoproteins and the development of chronic lymphocytic leukemia.
Original Research
Use of Fluorodeoxyglucose-Positron Emission Tomography in the Diagnosis of Intravascular Diffuse Large B-Cell Lymphoma
Patients with intravascular large B-cell lymphoma often pose a significant diagnostic challenge, particularly in the early stages of the disease,...
Article
γ-δ T-Cell Lymphoma With Disseminated Intravascular Coagulation and Autoimmune Hemolytic Anemia
This unique presentation may help in further characterizing and understanding this uncommon disease and in developing more effective therapies.
Original Research
Consensus Statement Supporting the Recommendation for Single-Fraction Palliative Radiotherapy for Uncomplicated, Painful Bone Metastases
Single-fraction palliative radiation therapy is a shorter course treatment option for veterans with terminal cancers and offers effective,...
Article
‘Strong evidence’ links obesity to cancers
A large umbrella review study of more than 200 meta-analyses finds that obesity is associated with a wide range of cancers.
Conference Coverage
Phase III trial: VZV protects auto-HCT patients
ORLANDO – An inactivated VZV vaccine for adults undergoing autologous hematopoietic stem cell transplantation has proven safe and effective.